- European stocks gain during Friday's session
- DAX on ATH ahead of US PCE data
European stock indices traded higher during Wednesday's session. The DAX is currently gaining 0.25% on an intraday basis on the podcast, while France's CAC40 is adding 0.4% over the same period. Investors' attention today turns to corporate news, companies' quarterly results and PCE data from the US.
Volatility currently seen in the European market. Source: xStation
The German DE40 index today extends its previous bullish momentum and breaks out to new historical peaks. The most important support for the index invariably remains the 50-day EMA (blue curve on the chart) and the recent peak broken out by the index in the 20,500-point zone. Technically, the DE40 continues to maintain a stable upward trend all the time. Source: xStation
News
Commerzbank (CBK.DE) is posting a net result of up to €2.7 billion in 2024 (analysts had expected €2.47 billion), while revenues rose 6% to €11.1 billion on the back of strong customer activity, the company reported. Return on equity rose to 9.2% (it was 7.7% in 2023). The dividend is expected to be €0.65 per share. The company's shares are gaining nearly 1% today.
Novartis (NOVN.CH) released financial results showing adjusted net income well above analysts' estimates, as sales of its acclaimed heart failure drug Entresto and newer multiple sclerosis drug Kesimpta exceeded forecasts. Net income for the fourth quarter, adjusted for special items, rose 26% to $3.93 billion (analysts had expected $3.64 billion).
J.B. Hunt gains 18% after strong quarterly results 🚀
Stock of the Week - Lam Research Corp (16.10.2025)
Salesforce surges 8% amid positive long-term revenue forecast📈
Thermo Fisher Scientific announces strategic collaboration with OpenAI📱
The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the client’s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any client’s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.
